eCTD Regulatory Submissions Network Blog providing status updates and discuss on current regulatory trends including eCTD Submissions and best practices in the development and delivery of global dossiers.your comments,feedback and discussion help for all.
06 September 2011
Generic Pharmaceutical Association position on FDA OGD funding
Generic Pharmaceutical Manufacturers endorses user fees to assure ANDA review timelines.
No comments:
Post a Comment